These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32722248)

  • 1. Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria.
    Park I; Johnson LK; Cox A; Branchford BR; Di Paola J; Bublil EM; Majtan T
    Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32722248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy.
    Majtan T; Park I; Cox A; Branchford BR; di Paola J; Bublil EM; Kraus JP
    FASEB J; 2019 Nov; 33(11):12477-12486. PubMed ID: 31450979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria.
    Park I; Bublil EM; Glavin F; Majtan T
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32971905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
    Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
    Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tract.
    Skvorak K; Mitchell V; Teadt L; Franklin KA; Lee HO; Kruse N; Huitt-Roehl C; Hang J; Du F; Galanie S; Guan S; Aijaz H; Zhang N; Rajkovic G; Kruger WD; Ismaili MHA; Huisman G; McCluskie K; Silverman AP
    Mol Genet Metab; 2023 Aug; 139(4):107653. PubMed ID: 37463544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model.
    Wang L; Chen X; Tang B; Hua X; Klein-Szanto A; Kruger WD
    Hum Mol Genet; 2005 Aug; 14(15):2201-8. PubMed ID: 15972722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function.
    Majtan T; Olsen T; Sokolova J; Krijt J; Křížková M; Ida T; Ditrói T; Hansikova H; Vit O; Petrak J; Kuchař L; Kruger WD; Nagy P; Akaike T; Kožich V
    Redox Biol; 2024 Jul; 73():103222. PubMed ID: 38843767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria.
    Majtan T; Jones W; Krijt J; Park I; Kruger WD; Kožich V; Bassnett S; Bublil EM; Kraus JP
    Mol Ther; 2018 Mar; 26(3):834-844. PubMed ID: 29398487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.
    Gupta S; Wang L; Kruger WD
    J Inherit Metab Dis; 2016 Jan; 39(1):39-46. PubMed ID: 26231230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurine alleviates repression of betaine-homocysteine
    Maclean KN; Jiang H; Phinney WN; Keating AK; Hurt KJ; Stabler SP
    FASEB J; 2019 May; 33(5):6339-6353. PubMed ID: 30768359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action and impact of thiol homeostasis on efficacy of an enzyme replacement therapy for classical homocystinuria.
    Philipp TM; Bottiglieri T; Clapper W; Liu K; Rodems S; Szabo C; Majtan T
    Redox Biol; 2024 Nov; 77():103383. PubMed ID: 39366068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies.
    Bublil EM; Majtan T
    Biochimie; 2020 Jun; 173():48-56. PubMed ID: 31857119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria.
    Majtan T; Park I; Bublil EM; Kraus JP
    Hum Mutat; 2018 Feb; 39(2):210-218. PubMed ID: 29044829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracetamol toxicity in classic homocystinuria: Effect of
    Elkhateeb N; Hyde S; Hogg SL; Allsop D; Shankar A; Deegan P; Tan CY
    JIMD Rep; 2023 May; 64(3):238-245. PubMed ID: 37151359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes.
    Jiang H; Stabler SP; Allen RH; Maclean KN
    Mol Genet Metab; 2012 Sep; 107(1-2):55-65. PubMed ID: 22633282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dietary modulation of sulfur amino acids on cystathionine β synthase-deficient mice.
    Kruger WD; Gupta S
    Ann N Y Acad Sci; 2016 Jan; 1363(1):80-90. PubMed ID: 26599618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.
    Dayal S; Chauhan AK; Jensen M; Leo L; Lynch CM; Faraci FM; Kruger WD; Lentz SR
    Blood; 2012 Mar; 119(13):3176-83. PubMed ID: 22186991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystathionine beta-synthase deficiency alters hepatic phospholipid and choline metabolism: Post-translational repression of phosphatidylethanolamine N-methyltransferase is a consequence rather than a cause of liver injury in homocystinuria.
    Jacobs RL; Jiang H; Kennelly JP; Orlicky DJ; Allen RH; Stabler SP; Maclean KN
    Mol Genet Metab; 2017 Apr; 120(4):325-336. PubMed ID: 28291718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Development of Newborn Screening for HCU and Current Challenges.
    Levy HL
    Int J Neonatal Screen; 2021 Oct; 7(4):. PubMed ID: 34842599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.